Mark C. Wiggins, Chief Business Officer at Tracon Pharmaceuticals, Inc. (TCON), bought 5,000 shares at $4.02 ($20K) on 2020-01-23, disclosed to the SEC on 2020-01-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ZGNX | BUY | 2020-03-24 | $51K | — | Filing → |
| ZGNX | SELL | 2019-08-12 | $313K | — | Filing → |
| BIIB | SELL | 2008-09-29 | $37K | — | Filing → |